Medical treatment of uveal melanoma

Tumori. 2007 May-Jun;93(3):suppl 27-30.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bendamustine Hydrochloride
  • Busulfan / administration & dosage
  • Busulfan / analogs & derivatives
  • Busulfan / therapeutic use
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Combined Modality Therapy
  • Dacarbazine / administration & dosage
  • Dacarbazine / analogs & derivatives
  • Dacarbazine / pharmacokinetics
  • Dacarbazine / therapeutic use
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Embolization, Therapeutic
  • Eye Enucleation
  • Gemcitabine
  • Humans
  • Hyperthermia, Induced / methods
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Liver Neoplasms / therapy
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Melanoma / secondary
  • Melanoma / surgery
  • Melanoma / therapy
  • Middle Aged
  • Multicenter Studies as Topic
  • Nitrogen Mustard Compounds / therapeutic use
  • Nitrosourea Compounds / pharmacokinetics
  • Nitrosourea Compounds / therapeutic use
  • Organophosphorus Compounds / pharmacokinetics
  • Organophosphorus Compounds / therapeutic use
  • Prognosis
  • Retrospective Studies
  • Temozolomide
  • Uveal Neoplasms / drug therapy*
  • Uveal Neoplasms / genetics
  • Uveal Neoplasms / surgery

Substances

  • Antineoplastic Agents, Alkylating
  • Nitrogen Mustard Compounds
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • Deoxycytidine
  • Dacarbazine
  • Bendamustine Hydrochloride
  • treosulfan
  • Busulfan
  • fotemustine
  • Temozolomide
  • Gemcitabine